MARÍA JESÚS
FERNÁNDEZ ACEÑERO
Profesora asociada
![Foto de Jesús](/img/nophoto.png)
Jesús
García-Foncillas López
Publications by the researcher in collaboration with Jesús García-Foncillas López (22)
2024
-
Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z)
British Journal of Cancer
-
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells
British Journal of Cancer, Vol. 130, Núm. 8, pp. 1402-1413
-
Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest
Molecular Oncology
2023
2021
-
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer
Biomedicine and Pharmacotherapy, Vol. 144
2020
-
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study
Neuroendocrinology, Vol. 110, Núm. 1-2, pp. 50-62
-
TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma
Pathology and Oncology Research, Vol. 26, Núm. 2, pp. 861-865
-
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas
Neuroendocrinology, Vol. 111, Núm. 1-2, pp. 146-157
-
The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer
Journal of Clinical Medicine, Vol. 9, Núm. 5
2019
-
Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients
Pathology and Oncology Research, Vol. 25, Núm. 1, pp. 269-278
-
The prognosis value of PIWIL1 and PIWIL2 expression in pancreatic cancer
Journal of Clinical Medicine, Vol. 8, Núm. 9
-
UNR/CSDE1 expression is critical to maintain invasive phenotype of colorectal cancer through regulation of c-MYC and epithelial-to-mesenchymal transition
Journal of Clinical Medicine, Vol. 8, Núm. 4
2018
2017
2016
-
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Pathology Research and Practice, Vol. 212, Núm. 12, pp. 1133-1137
-
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
Journal of Cellular and Molecular Medicine, Vol. 20, Núm. 9, pp. 1729-1736
-
PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma
Pathology and Oncology Research, Vol. 22, Núm. 2, pp. 377-383
-
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: A retrospective observational cohort study
BMC Cancer, Vol. 16, Núm. 1
2015
-
Identification of Poor-outcome Biliopancreatic Carcinoma Patients with Two-marker Signature Based on ATF6α and p-p38 "sTARD Compliant"
Medicine (United States), Vol. 94, Núm. 45, pp. e1972
-
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer
International Journal of Colorectal Disease, Vol. 30, Núm. 7, pp. 899-906